Pain Pumps & PAGCL: How An Attorney Can Help
UPDATED: May 5, 2016
It’s all about you. We want to help you make the right legal decisions.
We strive to help you make confident law decisions. Finding trusted and reliable legal advice should be easy. This doesn't influence our content. Our opinions are our own.
Shoulder surgery patients who used a pain pump during their recovery phase may be at an increased risk of developing Postarthroscopic Glenohumeral Chondrolysis (PAGCL), or shoulder arthroscopy, a very painful condition that may cause a permanent loss of mobility. So, how can a lawyer help?
Tapping into a product liability lawyer’s knowledge
If you’ve been injured due to a pain pump manufactured by Stryker, DJO Inc., I-Flow or BREG Inc., it’s important to find out as much as you can – as fast as you can. Experienced product liability lawyers who have been following the hundreds of pain pump lawsuits already filed across the county have the information you’re looking for. Tapping into that knowledge – even if you don’t end up pursuing a lawsuit – can be of great comfort. They’ll be able to assess whether you may have a lawsuit, discuss what damages might be available to you and, most importantly, explain why these manufacturers may be liable your injuries.
Why pain pump manufacturers may be liable for your injuries
Legal experts who have analyzed the pain pump litigation say that doctors who prescribe pain pumps may not realize the potential damage that these devices can cause. In fact, they say that doctors may actually know very little about the issue at all because manufacturers omitted warning labels about the dangers of inserting the pain pumps directly into the joint space of a patient’s shoulder – something that was never approved by the U.S. Food & Drug Administration (FDA), yet something that manufacturers know occurs every day.
What many patients don’t realize is that McKinley Medical (purchased by Stryker in 2000), asked the FDA whether it could promote the product by having doctors inject pain medication directly into the joint space of a patient’s shoulder. While the FDA requested that McKinley conduct studies about the effects of the process, the company doesn’t seem to have followed through.